Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study.
Electrophysiological studies, including electrooculogram (EOG), and simultaneously recorded flash and pattern evoked electroretinograms (FERG and PERG) and visually evoked potentials (FVEP and PVEP) were made in 1988 on 10 newly diagnosed untreated Parkinson's patients at Stage 1 of the Hoehn and Yahr scale. Follow up studies were made on five out of the 10 patients when their disease had progressed to Stage 2 during 1993. The earliest and only sign of abnormality detected in the Stage 1 of Parkinson's patients in 1988 was a delay in the time to reach the peak light rise in the EOG. When the disease had progressed to Stage 2, not only a delay in the time to reach the peak light rise but also a reduction in the amplitude of the peak light rise in the EOG, together with changes in PERG, FERG and PVEPs were demonstrable. These changes observed in PERG, FERG and PVEPs were generally consistent with those reported by previous studies. It is suggested that the reason for the susceptibility of pigment epithelial function to dopamine deficiency in Parkinson's disease may be due to the pigment epithelium being at the extremity of the diffusion pathway from dopamine release sites at the inner plexiform layer.
Vision Research Unit of Sherrington School (UMDS), Rayne Institute, St Thomas' Hospital, London, England.
H
H
Ikeda
G M
GM
Head
C J
CJ
Ellis
D000328:Adult; D000368:Aged; D004298:Dopamine / Q000172:deficiency*; D004585:Electrooculography; D004596:Electroretinography; D005074:Evoked Potentials, Visual / Q000502:physiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008027:Light; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology*; D010364:Pattern Recognition, Visual / Q000502:physiology; D012160:Retina / Q000378:metabolism* / Q000503:physiopathology; D013997:Time Factors
D004298:Dopamine